<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">ESRF Beamtime: MD 543</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<title level="a" type="main">ESRF Beamtime: MD 543</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">CD45E0CAA01B035AC2C8A5A7A286996E</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T22:48+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The main objective of the study was to investigate the possibility of producing a controlled drug release in neuron cells by using nanoparticles coated with an acid-sensitive polymer (PVP) and a drug and/or an imaging molecule for MRI investigations: Gd-DTPA. Results indicate that nanoparticles (NPs) are confined in the perinuclear region of the cells for all concentration tested.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>One of the main limitations in treating solid tumors with conventional chemotherapeutics is the difficulty in really accessing cancer cells, due particularly to defective vasculature in tumors and a sort of barriers that reduce a sufficient drug delivery. In addition, cancer drug resistance can develop rapidly for some aggressive tumors. A big help in treating cancer diseases could come from synergic cytotoxic activities and from attempts of imaging guided therapy. This is a recent concept in the expectations of nanomedicine, referred as theranostic approach. <ref type="bibr" target="#b0">1</ref> Amongst the different nanoparticles (NPs), magnetic and core-shell magnetic nanoparticles with different composition aimed to kill cancer cells by magnetically induced hypertermia have been developed. It is relevant that, magnetic nanoparticles could be suitable for treating brain tumors, because they can cross blood brain barrier. <ref type="bibr" target="#b1">2</ref> Moreover, multifunctional magnetic nanoparticles for drug and gene delivery and for in vivo applications in cancer diagnostic and therapy have also been investigated. <ref type="bibr">35</ref> We previously successfully applied XRF to reveal the presence of Gd containing drugs in different cell and tissue models for other purposes (and MD375, MD462 reports). Moreover, we have also used both ID21 at ESRF and TwinMic at ELETTRA to investigate the uptake and distribution of magnetic nanoparticles in Balb 3T3 mouse fibroblasts. <ref type="bibr" target="#b3">4</ref> Experimental approach Different types of magnetic nanoparticles have been used in this study. In particular, FeSi(Gd) NPs (15-80nm in diameter) have been synthesized at JRC. These nanoparticles consist of a Fe core (about 5-7 nm) surrounded by a silica other shell of ~20nm in diameter where the Gd-DTPA (Diethylenetriaminepentaacetic acid gadolinium(III) dihydrogen salt hydrate) compound has been inserted. Two different cell lines have been investigated: U87 human glioblastoma astrocytoma cell line and Balb 3T3 (mouse, fibroblasts) cells used as positive control. The cells were exposed to nanoparticles for 24 h at different concentrations (between 2 and 22 µg/mL). Other magnetic nanoparticles were also used for comparison: Fe 2 O 3 (maghemite) NPs of about 30 nm in diameter <ref type="bibr" target="#b4">5</ref> and cobalt ferrite (CoFe 2 O 3 ) of about 35nm (Colorobbia, Italy).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>TEM picture of U87 glioblastoma astrocytoma cell exposed to SiFe(Gd) NPs are reported in figure whilst XRF maps of Ca, P, Fe, and Gd are reported in figure <ref type="figure" target="#fig_1">2</ref>. As can be seen, TEM results indicate that the nanoparticles are able to enter different cell compartment (vesicles and endosomes) but not the nucleus. This is also confirmed by the XRF data (Figure <ref type="figure" target="#fig_1">2</ref>). The Fe and Gd maps show the confinement of the NPs in the perinuclear region of the cell, whilst the Ca and P signal are uniformly distributed in the cell indicating a cell healthy status. Moreover, the colocalization of Fe and Gd indicate that most of the Gd-DTPA is not released by the nanoparticles, probably because the entrapment into the silica outer shell is too strong and does not allow the release of Gd. On the other hand the nanoparticles seem well tolerated by the cells. In fact, the shape and morphology of cells after exposure to the FeSi(Gd) NPs are every similar to that of the control (Figure <ref type="figure" target="#fig_1">2</ref>) and the Ca, S and P (not shown) are uniformly distributed in the cell. XRF maps of U87 cells exposed to pure Gd-DTPA at the same concentrations and exposure times show a low but uniform Gd signal in the entire cell, with no accumulation of Gd in specific cell compartments. No major differences have been observed when increasing the NPs concentration 2µg/mL. However, in this case the Gd signal is very low and almost indistinguishable from the background. A similar behaviour has been observed for the other nanoparticles tested. However, in the case of the CoFe 2 O 4 the presence of Fe and Co in the nucleus of the cell has been detected by XRF spectroscopy. Moreover at high concentrations (&gt;115µg/mL) an excess of Co in the nuclear compartment together with a colocalization of Fe and Ca have been observed. <ref type="bibr" target="#b3">4</ref> This indicate that the CoFe 2 O 4 are much less stable than the FeSi(Gd) nanoparticles when in contact with biological environment. (a) (b) (c) (d) (e) (f) </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 :</head><label>1</label><figDesc>Figure 1: TEM picture of a U87 cell exposed to FESi(Gd) nanoparticles (22µg/mL for 24h)</figDesc><graphic coords="2,242.34,202.14,127.74,101.82" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 :</head><label>2</label><figDesc>Figure 2: SR-XRF maps of Ca (a, d), Fe (b, e) and Gd (c, f) of U87 glioblastoma cells: control(a, b, c) and exposed to FeSi(Gd) NPs (22µg/mL for 24 h).</figDesc><graphic coords="2,117.66,444.54,96.41,101.64" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Theranostic Nanomedicine for Cancer</title>
		<author>
			<persName><forename type="first">Baran</forename><surname>Sumer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jinming</forename><surname>Gao</surname></persName>
		</author>
		<idno type="DOI">10.2217/17435889.3.2.137</idno>
	</analytic>
	<monogr>
		<title level="j">Nanomedicine</title>
		<title level="j" type="abbrev">Nanomedicine</title>
		<idno type="ISSN">1743-5889</idno>
		<idno type="ISSNe">1748-6963</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="137" to="140" />
			<date type="published" when="2008-03-28">2008</date>
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">B. Sumer J. Gao, Nanomedicine, 3, (2008) 137</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Sharma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurochir Suppl</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page">359</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sharma HS, et al., Acta Neurochir Suppl.106, (2010), 359</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Preview: Angew. Chem. Int. Ed. 44/2005</title>
		<author>
			<persName><forename type="first">T.-J</forename><surname>Yoon</surname></persName>
		</author>
		<idno type="DOI">10.1002/anie.200590148</idno>
	</analytic>
	<monogr>
		<title level="j">Angewandte Chemie International Edition</title>
		<title level="j" type="abbrev">Angew Chem Int Ed</title>
		<idno type="ISSN">1433-7851</idno>
		<idno type="ISSNe">1521-3773</idno>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">44</biblScope>
			<biblScope unit="page" from="7313" to="7313" />
			<date type="published" when="2005-11-08">2005</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">T.-J. Yoon et al, Angew. Chem,. Int. Ed., 44, (2005), 1068</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Cellular distribution and degradation of cobalt ferrite nanoparticles in Balb/3T3 mouse fibroblasts</title>
		<author>
			<persName><forename type="first">Patrick</forename><surname>Marmorato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Giacomo</forename><surname>Ceccone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alessandra</forename><surname>Gianoncelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lorella</forename><surname>Pascolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jessica</forename><surname>Ponti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">François</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Murielle</forename><surname>Salomé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Burkhard</forename><surname>Kaulich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Maya</forename><surname>Kiskinova</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.toxlet.2011.08.026</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology Letters</title>
		<title level="j" type="abbrev">Toxicology Letters</title>
		<idno type="ISSN">0378-4274</idno>
		<imprint>
			<biblScope unit="volume">207</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="128" to="136" />
			<date type="published" when="2011-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>submitted</note>
	<note type="raw_reference">P. Marmorato, G. Ceccone et al, Toxicol. Lett. (submitted)</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Torres et al. (E-Surf Disc.): review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gyergyeka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Makovec</surname></persName>
		</author>
		<idno type="DOI">10.5194/esurf-2017-29-rc1</idno>
	</analytic>
	<monogr>
		<title level="j">Coll. Surf A</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page">113</biblScope>
			<date type="published" when="2010">2010</date>
			<publisher>Copernicus GmbH</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">S. Gyergyeka, D. Makovec, et al, Coll. Surf A, 366, (2010), 113</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
